Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study

NEXT STORY
Basilea announces data presentations at ESMO Virtual Congress 2020
PREV STORY
Brown & Brown, Inc. Announces Quarterly Revenues of $598.8 Million, an Increase of 4.1%; and Diluted Net Income Per Share of $0.34
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors

AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release March 31, 2017 at 10:00 EET Conversion of FIT Biotech ...

author_avatar
NASDAQ Market News

Capital Region Medical Center Selects Cerner Enterprisewide Health IT System

JEFFERSON CITY, Mo., May 07, 2018 (GLOBE NEWSWIRE) -- Capital Region Medical Center (CRMC) ...

author_avatar
NASDAQ Market News